Skip to main content
Clinical Trials/CTRI/2022/09/045565
CTRI/2022/09/045565
Not yet recruiting
Phase 3

ââ?¬Å?A clinical study to evaluate the effect of Shirodhara along with Abhyanga in the management of Generalised Anxiety Disorder(Atatvabhinivesh)

Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Jodhpur0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: F411- Generalized anxiety disorder
Sponsor
Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Jodhpur
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Jodhpur

Eligibility Criteria

Inclusion Criteria

  • 1 Post Covid Patients
  • 2 Patients with symptoms of Generalised Anxiety Disorder
  • 3 Hypertensive Patients

Exclusion Criteria

  • 1 Patients having serious systemic diseases like cardiac, renal or respiratory
  • 2 Patients unsuitable for Shirodhara and Abhyanga
  • 3 Patients taking any other treatment of Generalised Anxiety Disorder

Outcomes

Primary Outcomes

Not specified

Similar Trials